🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A protocol named as "HLH-DR" for patients with refractory and secondary hem...
Status
Unknown
Location
Yan Yue
Start Date
2017-03-01
Trial ID
NCT03795909
Treatments Being Tested
The purpose of the study is to assess the efficacy and safety of ruxolitini...
Status
Completed
Location
Clinical Research Center of Alabama
Start Date
2021-07-19
Trial ID
NCT04921969
Treatments Being Tested
The purpose of the study is to compare the efficacy of parsaclisib when com...
Status
Terminated
Location
Alaska Oncology and Hematology
Start Date
2021-05-24
Trial ID
NCT04551066
Treatments Being Tested
Phase 1, single -center study in 2 parts. The study designs for each part a...
Status
Completed
Location
Nucleus Network Brisbane
Start Date
2020-09-10
Trial ID
NCT04456634
This is a global, multicenter, 2-part study to evaluate the efficacy and sa...
Status
Active Not Recruiting
Location
UAB Division of Hematology/Oncology
Start Date
2021-03-11
Trial ID
NCT04562389
Treatments Being Tested
The purpose of this study was to determine if ruxolitinib, in combination w...
Status
Terminated
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT02119676
Treatments Being Tested
The purpose of the study is to compare the efficacy and safety of parsaclis...
Status
Terminated
Location
Sutter Health Alta Bates Summit Medical Center Absmc Alta Bates Summit Comprehensive Cancer Center
Start Date
2021-05-26
Trial ID
NCT04551053
Treatments Being Tested
The purpose of this trial is to evaluate whether treatment with pelabresib ...
Status
Recruiting
Location
Yale University School Of Medicine
Start Date
2026-06-08
Trial ID
NCT07357727
Treatments Being Tested
This was a randomized, double-blind, placebo-controlled phase 2 clinical tr...
Status
Terminated
Location
Multiple Locations
Start Date
2014-05
Trial ID
NCT02120417
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of ruxolit...
Status
Terminated
Location
Mayo Clinic
Start Date
2017-11-14
Trial ID
NCT03123588
Treatments Being Tested